Child nutrition · PLoS Med · 2020
B12’s effect on infant hemoglobin: the paper’s range is nine times wider than its numbers allow
Gap in end-of-study hemoglobin between the groups, with each range of plausible gaps
The paper says
A Nepalese trial gave 600 infants daily vitamin B12 or a placebo. Both groups’ hemoglobin (the blood’s oxygen carrier) ended at 11.6 g/dL. The paper’s summary and Table 3 put the gap at 0.02 g/dL, with a range of plausible gaps from −1.33 to 1.37.
Its own data show
Table 3 also prints each group’s size (283 and 290 infants) and how far infants typically were from their group’s average (0.8 and 1.0 g/dL). The textbook formula its footnote names (the Student t test) turns these into −0.13 to 0.17. The same method reproduces the other 22 ranges in the paper’s two results tables.
A range spans the gaps the data can’t rule out; nearly 300 infants per group make it narrow. The printed one allows a B12 effect over 1 g/dL, as big as each group’s rise during the study. The no-effect conclusion stands, but reviews pooling trials count wide-range ones less, so this one would count 1/82 as much as it should.